The increasing prevalence of acquired carbapenemases in Gram – negative bacteria is one of the biggest problems in the prevention and therapy of infectious diseases. NDM (New Delhi Metallo--Lactamase) is a recently discovered enzyme which has the ability to hydrolyze all -lactam antibiotics, except aztreonam. Making that scenario more worrisome is the fact that mobile fragments of DNA carrying blaNDM genes, also keeps a number of other genes encoding antibiotic resistance. NDM enzymes are currently present in different species of bacteria all over the world. NDM-producing bacteria are resistant to virtually all available antimicrobial agents except tigecycline, colistine and fosfomycine
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.